Geode Capital Management, LLC Bluebird Bio, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,683,042 shares of BLUE stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,683,042
Previous 4,516,271
3.69%
Holding current value
$1.83 Million
Previous $4.43 Million
44.97%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding BLUE
# of Institutions
160Shares Held
81.1MCall Options Held
525KPut Options Held
634K-
Black Rock Inc. New York, NY15.4MShares$6.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$4.08 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$2.49 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$2.01 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$1.82 Million0.02% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $30.1M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...